Could Revisiting US Approval Decisions Become Less Rare?

 
• By Derrick Gingery
  
FDAEntrance_1200x675
FDA Commissioner Stephen Hahn said approval speed does not have to be sacrificed to maintain safety and efficacy standards. • Source: File photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet